benefit
People at ‘intermediate risk’ of heart disease with elevated hsCRP benefit from statin therapy
August 26th, 2010
People at ‘intermediate risk’ of heart disease with elevated hsCRP benefit from statin therapy
People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein, a…